MFDS — authorised 29 January 2013
- Marketing authorisation holder: GENZYME CORP
- Status: likely_approved
🇰🇷 Kynamro in South Korea
MFDS authorised Kynamro on 29 January 2013
Marketing authorisation
Kynamro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Kynamro approved in South Korea?
Yes. MFDS authorised it on 29 January 2013.
Who is the marketing authorisation holder for Kynamro in South Korea?
GENZYME CORP holds the South Korean marketing authorisation.